-
1
-
-
0032789614
-
3 analog combined with 9-cis-retinoic acid markedly inhibits colony growth of prostate cancer cells
-
DOI 10.1002/(SICI)1097-0045(19990801)40:3<141::AID-PROS1>3.0.CO;2-C
-
E Elstner MJ Campbell R Munker P Shintaku L Binderup D Heber J Said HP Koeffler 1999 Novel 20-epi-vitamin D3 analog combined with 9-cis-retinoic acid markedly inhibits colony growth of prostate cancer cells Prostate 40 141 149 10.1002/(SICI)1097-0045(19990801)40:3<141::AID-PROS1>3.0.CO;2-C 1:CAS:528:DyaK1MXltVCltLw%3D 10398275 (Pubitemid 29334861)
-
(1999)
Prostate
, vol.40
, Issue.3
, pp. 141-149
-
-
Elstner, E.1
Campbell, M.J.2
Munker, R.3
Shintaku, P.4
Binderup, L.5
Heber, D.6
Said, J.7
Koeffler, H.P.8
-
2
-
-
0035922176
-
Evaluation of the chemopreventive potential of retinoids using a novel in vitro human prostate carcinogenesis model
-
1:CAS:528:DC%2BD3MXls1ehtLs%3D 11551491
-
ST Quader D Bello-DeOcampo DE Williams HK Kleinman MM Webber 2001 Evaluation of the chemopreventive potential of retinoids using a novel in vitro human prostate carcinogenesis model Mutat Res 496 153 161 1:CAS:528: DC%2BD3MXls1ehtLs%3D 11551491
-
(2001)
Mutat Res
, vol.496
, pp. 153-161
-
-
Quader, S.T.1
Bello-Deocampo, D.2
Williams, D.E.3
Kleinman, H.K.4
Webber, M.M.5
-
3
-
-
0034139318
-
Nutritional aspects of prostate cancer: A review
-
1:STN:280:DC%2BD3MzptlWluw%3D%3D 11121247 discussion 936
-
AJ Blumenfeld N Fleshner B Casselman J Trachtenberg 2000 Nutritional aspects of prostate cancer: a review Can J Urol 7 927 935 1:STN:280: DC%2BD3MzptlWluw%3D%3D 11121247 discussion 936
-
(2000)
Can J Urol
, vol.7
, pp. 927-935
-
-
Blumenfeld, A.J.1
Fleshner, N.2
Casselman, B.3
Trachtenberg, J.4
-
4
-
-
33645900577
-
Relationship between plasma carotenoids and prostate cancer
-
10.1207/s15327914nc5302-1 1:CAS:528:DC%2BD28Xksl2hsbo%3D 16573373
-
S Chang JW Erdman Jr SK Clinton M Vadiveloo SS Strom Y Yamamura CM Duphorne MR Spitz CI Amos JH Contois X Gu RJ Babaian PT Scardino SD Hursting 2005 Relationship between plasma carotenoids and prostate cancer Nutr Cancer 53 127 134 10.1207/s15327914nc5302-1 1:CAS:528:DC%2BD28Xksl2hsbo%3D 16573373
-
(2005)
Nutr Cancer
, vol.53
, pp. 127-134
-
-
Chang, S.1
Erdman Jr, J.W.2
Clinton, S.K.3
Vadiveloo, M.4
Strom, S.S.5
Yamamura, Y.6
Duphorne, C.M.7
Spitz, M.R.8
Amos, C.I.9
Contois, J.H.10
Gu, X.11
Babaian, R.J.12
Scardino, P.T.13
Hursting, S.D.14
-
5
-
-
0034564791
-
Prostate cancer. What part does diet play?
-
1:STN:280:DC%2BD3M%2FpslKiuw%3D%3D 11140214
-
T Brett 2000 Prostate cancer. What part does diet play? Aust Fam Physician 29 1122 1124 1:STN:280:DC%2BD3M%2FpslKiuw%3D%3D 11140214
-
(2000)
Aust Fam Physician
, vol.29
, pp. 1122-1124
-
-
Brett, T.1
-
6
-
-
31544457383
-
Vitamin antioxidants, lipid peroxidation and the systemic inflammatory response in patients with prostate cancer
-
DOI 10.1002/ijc.21451
-
AS Almushatat D Talwar PA McArdle C Williamson N Sattar DS O'Reilly MA Underwood DC McMillan 2006 Vitamin antioxidants, lipid peroxidation and the systemic inflammatory response in patients with prostate cancer Int J Cancer 118 1051 1053 10.1002/ijc.21451 1:CAS:528:DC%2BD28XhtlaisLc%3D 16106418 (Pubitemid 43157684)
-
(2006)
International Journal of Cancer
, vol.118
, Issue.4
, pp. 1051-1053
-
-
Almushatat, A.S.K.1
Talwar, D.2
McArdle, P.A.3
Williamson, C.4
Sattar, N.5
O'Reilly, D.St.J.6
Underwood, M.A.7
McMillan, D.C.8
-
7
-
-
0038244793
-
Selenium supplementation, baseline plasma selenium status and incidence of prostate cancer: An analysis of the complete treatment period of the Nutritional Prevention of Cancer Trial
-
DOI 10.1046/j.1464-410X.2003.04167.x
-
AJ Duffield-Lillico BL Dalkin ME Reid BW Turnbull EH Slate ET Jacobs JR Marshall LC Clark 2003 Selenium supplementation, baseline plasma selenium status and incidence of prostate cancer: an analysis of the complete treatment period of the Nutritional Prevention of Cancer Trial BJU Int 91 608 612 10.1046/j.1464-410X.2003.04167.x 1:CAS:528:DC%2BD3sXks1ynu70%3D 12699469 (Pubitemid 36583728)
-
(2003)
BJU International
, vol.91
, Issue.7
, pp. 608-612
-
-
Duffield-Lillico, A.J.1
Dalkin, B.L.2
Reid, M.E.3
Turnbull, B.W.4
Slate, E.H.5
Jacobs, E.T.6
Marshall, J.R.7
Clark, L.C.8
-
8
-
-
0033405270
-
Nutrients in the chemoprevention of prostate cancer: Current and future prospects
-
NB Kumar K Besterman-Dahan 1999 Nutrients in the chemoprevention of prostate cancer: current and future prospects Cancer Control 6 580 586 10756389 (Pubitemid 30003279)
-
(1999)
Cancer Control
, vol.6
, Issue.6
, pp. 580-586
-
-
Kumar, N.B.1
Besterman-Dahan, K.2
-
9
-
-
14044274647
-
Serum α-tocopherol and γ-tocopherol in relation to prostate cancer risk in a prospective study
-
DOI 10.1093/jnci/dji045
-
SJ Weinstein ME Wright P Pietinen I King C Tan PR Taylor J Virtamo D Albanes 2005 Serum alpha-tocopherol and gamma-tocopherol in relation to prostate cancer risk in a prospective study J Natl Cancer Inst 97 396 399 1:CAS:528:DC%2BD2MXitV2jsLc%3D 15741576 (Pubitemid 40425958)
-
(2005)
Journal of the National Cancer Institute
, vol.97
, Issue.5
, pp. 396-399
-
-
Weinstein, S.J.1
Wright, M.E.2
Pietinen, P.3
King, I.4
Tan, C.5
Taylor, P.R.6
Virtamo, J.7
Albanes, D.8
-
10
-
-
0031819215
-
Decreased incidence of prostate cancer with selenium supplementation: Results of a double-blind cancer prevention trial
-
DOI 10.1046/j.1464-410X.1998.00630.x
-
LC Clark B Dalkin A Krongrad GF Combs Jr BW Turnbull EH Slate R Witherington JH Herlong E Janosko D Carpenter C Borosso S Falk J Rounder 1998 Decreased incidence of prostate cancer with selenium supplementation: results of a double-blind cancer prevention trial Br J Urol 81 730 734 1:CAS:528:DyaK1cXjslGksbY%3D 9634050 (Pubitemid 28316638)
-
(1998)
British Journal of Urology
, vol.81
, Issue.5
, pp. 730-734
-
-
Clark, L.C.1
Dalkin, B.2
Krongrad, A.3
Combs Jr., G.F.4
Turnbull, B.W.5
Slate, E.H.6
Witherington, R.7
Herlong, J.H.8
Janosko, E.9
Carpenter, D.10
Borosso, C.11
Falk, S.12
Rounder, J.13
-
11
-
-
0034906966
-
Phase II randomized clinical trial of lycopene supplementation before radical prostatectomy
-
O Kucuk FH Sarkar W Sakr Z Djuric MN Pollak F Khachik YW Li M Banerjee D Grignon JS Bertram JD Crissman EJ Pontes DP Wood Jr 2001 Phase II randomized clinical trial of lycopene supplementation before radical prostatectomy Cancer Epidemiol Biomarkers Prev 10 861 868 1:CAS:528:DC%2BD3MXmsF2rur8%3D 11489752 (Pubitemid 32738598)
-
(2001)
Cancer Epidemiology Biomarkers and Prevention
, vol.10
, Issue.8
, pp. 861-868
-
-
Kucuk, O.1
Sarkar, F.H.2
Sakr, W.3
Djuric, Z.4
Pollak, M.N.5
Khachik, F.6
Li, Y.-W.7
Banerjee, M.8
Grignon, D.9
Bertram, J.S.10
Crissman, J.D.11
Pontes, E.J.12
Wood Jr., D.P.13
-
12
-
-
0036847259
-
Effects of lycopene supplementation in patients with localized prostate cancer
-
O Kucuk FH Sarkar Z Djuric W Sakr MN Pollak F Khachik M Banerjee JS Bertram DP Wood Jr 2002 Effects of lycopene supplementation in patients with localized prostate cancer Exp Biol Med (Maywood) 227 881 885 1:CAS:528:DC%2BD38Xos1ygu7Y%3D (Pubitemid 35340342)
-
(2002)
Experimental Biology and Medicine
, vol.227
, Issue.10
, pp. 881-885
-
-
Kucuk, O.1
Sarkar, F.H.2
Djuric, Z.3
Sakr, W.4
Pollak, M.N.5
Khachik, F.6
Banerjee, M.7
Bertram, J.S.8
Wood Jr., D.P.9
-
13
-
-
0041910043
-
A comparison of lycopene and orchidectomy vs orchidectomy alone in the management of advanced prostate cancer
-
DOI 10.1046/j.1464-410X.2003.04370.x
-
MS Ansari NP Gupta 2003 A comparison of lycopene and orchidectomy vs orchidectomy alone in the management of advanced prostate cancer BJU Int 92 375 378 10.1046/j.1464-410X.2003.04370.x 1:STN:280:DC%2BD3szptlaiug%3D%3D 12930422 discussion 378. (Pubitemid 37100511)
-
(2003)
BJU International
, vol.92
, Issue.4
, pp. 375-378
-
-
Ansari, M.S.1
Gupta, N.P.2
-
14
-
-
23244433163
-
Selection of surrogate endpoint biomarkers to evaluate the efficacy of lycopene/tomatoes for the prevention/progression of prostate cancer
-
1:CAS:528:DC%2BD2MXps1yisLw%3D 16046745
-
PE Bowen 2005 Selection of surrogate endpoint biomarkers to evaluate the efficacy of lycopene/tomatoes for the prevention/progression of prostate cancer J Nutr 135 2068S 2070S 1:CAS:528:DC%2BD2MXps1yisLw%3D 16046745
-
(2005)
J Nutr
, vol.135
-
-
Bowen, P.E.1
-
15
-
-
4544361438
-
Retinoic acid slows progression and promotes apoptosis of spontaneous prostate cancer
-
DOI 10.1002/pros.20097
-
WJ Huss L Lai RJ Barrios KK Hirschi NM Greenberg 2004 Retinoic acid slows progression and promotes apoptosis of spontaneous prostate cancer Prostate 61 142 152 10.1002/pros.20097 1:CAS:528:DC%2BD2cXosVKmu7Y%3D 15305337 (Pubitemid 39244701)
-
(2004)
Prostate
, vol.61
, Issue.2
, pp. 142-152
-
-
Huss, W.J.1
Lai, L.2
Barrios, R.J.3
Hirschi, K.K.4
Greenberg, N.M.5
-
16
-
-
0038613831
-
The role of vitamin D and retinoids in controlling prostate cancer progression
-
DOI 10.1677/erc.0.0100131
-
DM Peehl D Feldman 2003 The role of vitamin D and retinoids in controlling prostate cancer progression Endocr Relat Cancer 10 131 140 10.1677/erc.0.0100131 1:CAS:528:DC%2BD3sXmsFCku7Y%3D 12790775 (Pubitemid 36758642)
-
(2003)
Endocrine-Related Cancer
, vol.10
, Issue.2
, pp. 131-140
-
-
Peehl, D.M.1
Feldman, D.2
-
17
-
-
58149383852
-
Effect of selenium and vitamin e on risk of prostate cancer and other cancers: The Selenium and Vitamin e Cancer Prevention Trial (SELECT)
-
10.1001/jama.2008.864 1:CAS:528:DC%2BD1MXntFKmsw%3D%3D 19066370
-
SM Lippman EA Klein PJ Goodman MS Lucia IM Thompson LG Ford HL Parnes LM Minasian JM Gaziano JA Hartline JK Parsons JD Bearden 3rd ED Crawford GE Goodman J Claudio E Winquist ED Cook DD Karp P Walther MM Lieber AR Kristal AK Darke KB Arnold PA Ganz RM Santella D Albanes PR Taylor JL Probstfield TJ Jagpal JJ Crowley FL Meyskens Jr LH Baker CA Coltman Jr 2009 Effect of selenium and vitamin E on risk of prostate cancer and other cancers: the Selenium and Vitamin E Cancer Prevention Trial (SELECT) Jama 301 39 51 10.1001/jama.2008.864 1:CAS:528:DC%2BD1MXntFKmsw%3D%3D 19066370
-
(2009)
Jama
, vol.301
, pp. 39-51
-
-
Lippman, S.M.1
Klein, E.A.2
Goodman, P.J.3
Lucia, M.S.4
Thompson, I.M.5
Ford, L.G.6
Parnes, H.L.7
Minasian, L.M.8
Gaziano, J.M.9
Hartline, J.A.10
Parsons, J.K.11
Bearden III, J.D.12
Crawford, E.D.13
Goodman, G.E.14
Claudio, J.15
Winquist, E.16
Cook, E.D.17
Karp, D.D.18
Walther, P.19
Lieber, M.M.20
Kristal, A.R.21
Darke, A.K.22
Arnold, K.B.23
Ganz, P.A.24
Santella, R.M.25
Albanes, D.26
Taylor, P.R.27
Probstfield, J.L.28
Jagpal, T.J.29
Crowley, J.J.30
Meyskens Jr., F.L.31
Baker, L.H.32
Coltman Jr., C.A.33
more..
-
18
-
-
30744450505
-
Active surveillance with selective delayed intervention for favorable risk prostate cancer
-
DOI 10.1016/j.urolonc.2005.07.002, PII S1078143905001675
-
L Klotz 2006 Active surveillance with selective delayed intervention for favorable risk prostate cancer Urol Oncol 24 46 50 16414494 (Pubitemid 43097357)
-
(2006)
Urologic Oncology: Seminars and Original Investigations
, vol.24
, Issue.1
, pp. 46-50
-
-
Klotz, L.1
-
19
-
-
0742323730
-
Active surveillance: Towards a new paradigm in the management of early prostate cancer
-
DOI 10.1016/S1470-2045(04)01384-1, PII S1470204504013841
-
C Parker 2004 Active surveillance: towards a new paradigm in the management of early prostate cancer Lancet Oncol 5 101 106 10.1016/S1470- 2045(04)01384-1 14761814 (Pubitemid 38145893)
-
(2004)
Lancet Oncology
, vol.5
, Issue.2
, pp. 101-106
-
-
Parker, C.1
-
20
-
-
16644379926
-
Active surveillance of early prostate cancer: Rationale, initial results and future developments
-
DOI 10.1038/sj.pcan.4500720, PII 4500720
-
C Parker 2004 Active surveillance of early prostate cancer: rationale, initial results and future developments Prostate Cancer Prostatic Dis 7 184 187 10.1038/sj.pcan.4500720 1:STN:280:DC%2BD2cvjslOktA%3D%3D 15224088 (Pubitemid 41741500)
-
(2004)
Prostate Cancer and Prostatic Diseases
, vol.7
, Issue.3
, pp. 184-187
-
-
Parker, C.1
-
21
-
-
77749286517
-
Short-term outcomes of the prospective multicentre 'Prostate Cancer Research International: Active surveillance' study
-
2009 Oct 8
-
van den Bergh RC, Vasarainen H, van der Poel HG, Vis-Maters JJ, Rietbergen JB, Pickles T, et al. Short-term outcomes of the prospective multicentre 'Prostate Cancer Research International: Active Surveillance' study. BJU Int 2009 Oct 8.
-
BJU Int
-
-
Van Den Bergh, R.C.1
Vasarainen, H.2
Van Der Poel, H.G.3
Vis-Maters, J.J.4
Rietbergen, J.B.5
Pickles, T.6
-
22
-
-
27244436474
-
Active surveillance for good risk prostate cancer: Rationale, method, and results
-
16018828
-
LH Klotz 2005 Active surveillance for good risk prostate cancer: rationale, method, and results Can J Urol 12 Suppl 2 21 24 16018828
-
(2005)
Can J Urol
, vol.12
, Issue.SUPPL 2
, pp. 21-24
-
-
Klotz, L.H.1
-
23
-
-
20444476199
-
Active surveillance with selective delayed intervention is the way to manage 'good-risk' prostate cancer
-
DOI 10.1038/ncpuro0124
-
L Klotz 2005 Active surveillance with selective delayed intervention is the way to manage 'good-risk' prostate cancer Nat Clin Pract Urol 2 136 142 10.1038/ncpuro0124 16474710 quiz 131 p following 149 (Pubitemid 40812444)
-
(2005)
Nature Clinical Practice Urology
, vol.2
, Issue.3
, pp. 136-142
-
-
Klotz, L.1
-
24
-
-
22844433445
-
Pretreatment PSA velocity and risk of death from prostate cancer following external beam radiation therapy
-
DOI 10.1001/jama.294.4.440
-
AV D'Amico AA Renshaw B Sussman MH Chen 2005 Pretreatment PSA velocity and risk of death from prostate cancer following external beam radiation therapy Jama 294 440 447 10.1001/jama.294.4.440 16046650 (Pubitemid 41124176)
-
(2005)
Journal of the American Medical Association
, vol.294
, Issue.4
, pp. 440-447
-
-
D'Amico, A.V.1
Renshaw, A.A.2
Sussman, B.3
Chen, M.-H.4
-
25
-
-
37349039305
-
Prostate-specific antigen velocity in untreated, localized prostate cancer
-
DOI 10.1111/j.1464-410X.2007.07175.x
-
R Venkitaraman A Norman R Woode-Amissah D Dearnaley A Horwich R Huddart C Parker 2008 Prostate-specific antigen velocity in untreated, localized prostate cancer BJU Int 101 161 164 1:CAS:528:DC%2BD1cXitFKntrc%3D 17850368 (Pubitemid 350294036)
-
(2008)
BJU International
, vol.101
, Issue.2
, pp. 161-164
-
-
Venkitaraman, R.1
Norman, A.2
Woode-Amissah, R.3
Dearnaley, D.4
Horwich, A.5
Huddart, R.6
Parker, C.7
-
26
-
-
34547670085
-
Predictors of histological disease progression in untreated, localized prostate cancer
-
DOI 10.1016/j.juro.2007.05.038, PII S0022534707012438
-
R Venkitaraman A Norman R Woode-Amissah C Fisher D Dearnaley A Horwich R Huddart V Khoo A Thompson C Parker 2007 Predictors of histological disease progression in untreated, localized prostate cancer J Urol 178 833 837 10.1016/j.juro.2007.05.038 17631355 (Pubitemid 47211073)
-
(2007)
Journal of Urology
, vol.178
, Issue.3
, pp. 833-837
-
-
Venkitaraman, R.1
Norman, A.2
Woode-Amissah, R.3
Fisher, C.4
Dearnaley, D.5
Horwich, A.6
Huddart, R.7
Khoo, V.8
Thompson, A.9
Parker, C.10
-
27
-
-
67349157590
-
Biopsy tissue microarray study of Ki-67 expression in untreated, localized prostate cancer managed by active surveillance
-
10.1038/pcan.2008.47 1:CAS:528:DC%2BD1MXls12gtbg%3D 18762814
-
S Jhavar J Bartlett G Kovacs C Corbishley D Dearnaley R Eeles V Khoo R Huddart A Horwich A Thompson A Norman D Brewer CS Cooper C Parker 2009 Biopsy tissue microarray study of Ki-67 expression in untreated, localized prostate cancer managed by active surveillance Prostate Cancer Prostatic Dis 12 143 147 10.1038/pcan.2008.47 1:CAS:528:DC%2BD1MXls12gtbg%3D 18762814
-
(2009)
Prostate Cancer Prostatic Dis
, vol.12
, pp. 143-147
-
-
Jhavar, S.1
Bartlett, J.2
Kovacs, G.3
Corbishley, C.4
Dearnaley, D.5
Eeles, R.6
Khoo, V.7
Huddart, R.8
Horwich, A.9
Thompson, A.10
Norman, A.11
Brewer, D.12
Cooper, C.S.13
Parker, C.14
-
28
-
-
0033559952
-
Lower prostate cancer risk in men with elevated plasma lycopene levels: Results of a prospective analysis
-
PH Gann J Ma E Giovannucci W Willett FM Sacks CH Hennekens MJ Stampfer 1999 Lower prostate cancer risk in men with elevated plasma lycopene levels: results of a prospective analysis Cancer Res 59 1225 1230 1:CAS:528: DyaK1MXhvFehtLo%3D 10096552 (Pubitemid 29136251)
-
(1999)
Cancer Research
, vol.59
, Issue.6
, pp. 1225-1230
-
-
Gann, P.H.1
Ma, J.2
Giovannucci, E.3
Willett, W.4
Sacks, F.M.5
Hennekens, C.H.6
Stampfer, M.J.7
-
29
-
-
27844476337
-
Lycopene as a chemopreventive agent in the treatment of high-grade prostate intraepithelial neoplasia
-
DOI 10.1016/j.urolonc.2005.05.012, PII S1078143905001055, Treatment of Patients with Testis Cancer
-
NK Mohanty S Saxena UP Singh NK Goyal RP Arora 2005 Lycopene as a chemopreventive agent in the treatment of high-grade prostate intraepithelial neoplasia Urol Oncol 23 383 385 1:CAS:528:DC%2BD2MXht1Ghur7F 16301113 (Pubitemid 41654502)
-
(2005)
Urologic Oncology: Seminars and Original Investigations
, vol.23
, Issue.6
, pp. 383-385
-
-
Mohanty, N.K.1
Saxena, S.2
Singh, U.P.3
Goyal, N.K.4
Arora, R.P.5
-
30
-
-
20444415998
-
Role of lycopene and tomato products in prostate health
-
DOI 10.1016/j.bbadis.2005.02.004, PII S092544390500013X, Carotenoids and Dietary Lipids
-
M Stacewicz-Sapuntzakis PE Bowen 2005 Role of lycopene and tomato products in prostate health Biochim Biophys Acta 1740 202 205 1:CAS:528:DC%2BD2MXltFCrt7c%3D 15949687 (Pubitemid 40798230)
-
(2005)
Biochimica et Biophysica Acta - Molecular Basis of Disease
, vol.1740
, Issue.2
, pp. 202-205
-
-
Stacewicz-Sapuntzakis, M.1
Bowen, P.E.2
-
31
-
-
38149130693
-
Vitamin e and selenium supplementation and risk of prostate cancer in the Vitamins and Lifestyle (VITAL) Study cohort
-
10.1007/s10552-007-9072-y 17943452
-
U Peters AJ Littman AR Kristal RE Patterson JD Potter E White 2008 Vitamin E and selenium supplementation and risk of prostate cancer in the Vitamins and Lifestyle (VITAL) Study cohort Cancer Causes Control 19 75 87 10.1007/s10552-007-9072-y 17943452
-
(2008)
Cancer Causes Control
, vol.19
, pp. 75-87
-
-
Peters, U.1
Littman, A.J.2
Kristal, A.R.3
Patterson, R.E.4
Potter, J.D.5
White, E.6
-
32
-
-
58149375890
-
Vitamins e and C in the prevention of prostate and total cancer in men: The Physicians' Health Study II randomized controlled trial
-
10.1001/jama.2008.862 1:CAS:528:DC%2BD1MXntFKmsA%3D%3D 19066368
-
JM Gaziano RJ Glynn WG Christen T Kurth C Belanger J MacFadyen V Bubes JE Manson HD Sesso JE Buring 2009 Vitamins E and C in the prevention of prostate and total cancer in men: the Physicians' Health Study II randomized controlled trial JAMA 301 52 62 10.1001/jama.2008.862 1:CAS:528:DC%2BD1MXntFKmsA%3D%3D 19066368
-
(2009)
JAMA
, vol.301
, pp. 52-62
-
-
Gaziano, J.M.1
Glynn, R.J.2
Christen, W.G.3
Kurth, T.4
Belanger, C.5
MacFadyen, J.6
Bubes, V.7
Manson, J.E.8
Sesso, H.D.9
Buring, J.E.10
-
33
-
-
42249093703
-
Dietary intake of vitamin K and risk of prostate cancer in the Heidelberg cohort of the European Prospective Investigation into Cancer and Nutrition (EPIC-Heidelberg)
-
NE Allen PN Appleby AW Roddam A Tjonneland NF Johnsen K Overvad H Boeing S Weikert R Kaaks J Linseisen A Trichopoulou G Misirli D Trichopoulos C Sacerdote S Grioni D Palli R Tumino HB Bueno-de-Mesquita LA Kiemeney A Barricarte N Larranaga MJ Sanchez A Agudo MJ Tormo L Rodriguez P Stattin G Hallmans S Bingham KT Khaw N Slimani S Rinaldi P Boffetta E Riboli TJ Key 2008 Plasma selenium concentration and prostate cancer risk: results from the European Prospective Investigation into Cancer and Nutrition (EPIC) Am J Clin Nutr 88 1567 1575 10.3945/ajcn.2008.26205 1:CAS:528:DC%2BD1MXhvVygtb4%3D 19064517 (Pubitemid 351549245)
-
(2008)
American Journal of Clinical Nutrition
, vol.87
, Issue.4
, pp. 985-992
-
-
Nimptsch, K.1
Rohrmann, S.2
Linseisen, J.3
-
34
-
-
27844494837
-
Randomized, double-blind, placebo-controlled crossover study in men with prostate cancer and rising PSA: Effectiveness of a dietary supplement
-
DOI 10.1016/j.eururo.2005.08.005, PII S030228380500521X
-
FH Schroder MJ Roobol ER Boeve R de Mutsert SD Zuijdgeest-van Leeuwen I Kersten MF Wildhagen A van Helvoort 2005 Randomized, double-blind, placebo-controlled crossover study in men with prostate cancer and rising PSA: effectiveness of a dietary supplement Eur Urol 48 922 930 10.1016/j.eururo.2005. 08.005 16263208 discussion 930-921 (Pubitemid 41641637)
-
(2005)
European Urology
, vol.48
, Issue.6
, pp. 922-930
-
-
Schroder, F.H.1
Roobol, M.J.2
Boeve, E.R.3
De Mutsert, R.4
Zuijdgeest-Van Leeuwen, S.D.5
Kersten, I.6
Wildhagen, M.F.7
Van Helvoort, A.8
|